ZHANG Cheng-cheng, JI Qing, YANG Yue, et al. Effect of Feiyanning Formula on Invasion and Metastasis of Lung Cancer Inhibiting TGF- Mediated Bone Metastasis Related PTHrP/RANKL Signaling Pathway[J]. Chinese journal of experimental traditional medical formulae, 2018, 24(3): 132-136.
DOI:
ZHANG Cheng-cheng, JI Qing, YANG Yue, et al. Effect of Feiyanning Formula on Invasion and Metastasis of Lung Cancer Inhibiting TGF- Mediated Bone Metastasis Related PTHrP/RANKL Signaling Pathway[J]. Chinese journal of experimental traditional medical formulae, 2018, 24(3): 132-136. DOI: 10.13422/j.cnki.syfjx.2018030132.
Effect of Feiyanning Formula on Invasion and Metastasis of Lung Cancer Inhibiting TGF- Mediated Bone Metastasis Related PTHrP/RANKL Signaling Pathway
目的:探讨肺岩宁方通过调控转化生长因子-β(transforming growth factor-β,TGF-β)介导的骨转移相关甲状旁腺激素相关蛋白(parathyroid hormone-related protein,PTHrP)/NF-κB受体活化因子配体(receptor or activator of NF-κB ligand,RANKL)信号通路抗肺癌细胞侵袭转移的作用机制。方法:体外培养A549肺癌细胞,用不同终浓度肺岩宁方进行处理,未加肺岩宁方为空白组。分别采用cell counting kit-8(CCK-8)检测肺岩宁方对A549细胞增殖抑制作用,计算半数浓度抑制率(IC50);采用转移小室(transwell)侵袭实验、划痕实验检测肺岩宁方对A549细胞体外侵袭及迁移的抑制作用;以及蛋白免疫印迹法(Western blot)检测TGF-β,PTHrP,RANKL蛋白表达。结果:肺岩宁方作用于A549肺癌细胞48 h后,与空白组相比,肺岩宁方(12.5,25,50 mg·L-1)组穿膜细胞明显减少(P<0.05,P<0.01);肺岩宁方(12.5,25,50 mg·L-1)组的划痕距离较空白组明显降低(P<0.05,P<0.01);且肺岩宁方(25,50 mg·L-1)组作用于A549细胞后,TGF-β蛋白表达明显下调(P<0.05),其对应下游靶基因PTHrP及RANKL蛋白也发生明显表达下调(P<0.05)。结论:肺岩宁方可抑制A549肺癌细胞的侵袭迁移能力,直接下调TGF-β基因及其下游靶基因PTHrP,RANKL蛋白表达,且具有浓度相关性。本研究证实了肺岩宁方通过调控TGF-β介导的骨转移相关PTHrP/RANKL信号通路,以达到抗肺癌侵袭转移的作用机制,这为肺癌临床靶向治疗提供了一定的实验依据,也显示了肺岩宁方作为抗肺癌侵袭转移药物广泛的应用前景。
Abstract
Objective:To investigate the effect mechanism of Feiyanning formula on invasion and metastasis of lung cancer cells via inhibiting transforming growth factor-β (TGF-β) mediated bone metastasis related parathyroid hormone-related protein (PTHrP)/receptor or activator of NF-κB ligand (RANKL) signaling pathway. Method:A549 cells were cultured in vitro and treated with Feiyanning formula with various concentrations
with no Feiyanning formula as blank group. The anti-proliferation effects and the 50% inhibitory concentration (IC50) of Feiyanning formula was measured by cell counting kit-8 (CCK-8) method. The inhibiting effect against invasion and migration ability of A549 cells was detected by transwell assay and scratch test. Western blot was used to detect the protein expression of TGF-β
parathyroid hormone-related protein (PTHrP) and receptor or activator of NF-κB ligand (RANKL). Result:After Feiyanning formula effected on A549 lung cancer cells for 48 h
as compared with blank control group
the transmembrane cells in the low
medium and high dose Feiyanning formula (12.5
25
50 mg·L-1) groups were obviously reduced (P<0.05
P<0.01)
and the scratch distance in Feiyanning formula groups was also significantly shortened (P<0.05
P<0.01). Furthermore
medium and high dose Feiyanning formula group significantly down-regulated the expression of TGF-β (P<0.05) and its corresponding downstream target genes of PTHrP and RANKL (P<0.05). Conclusion:Feiyanning formula can directly down-regulate the protein expression of TGF-β and its downstream target genes PTHrP and RANKL
and inhibit the invasion and migration ability of A549 lung cancer cells in a concentration-dependent manner. This study confirmed the mechanism of Feiyanning formula on inhibiting the invasion and migration of lung cancer by regulating TGF-β mediated bone metastasis related PTHrP/RANKL signaling pathway
providing a certain experimental basis for the clinical target therapy of lung cancer
suggesting that Feiyanning formula could be a potential candidate in the treatment of lung cancer cell bone metastasis.
Effect of Wenyang Sanjie Prescription on Tumor Inhibition and STAT3/HIF-1α Pathway in Lung Cancer Tumor-bearing Mice
Invasion and Metastasis Inhibition of Lung Cancer by Traditional Chinese Medicine: A Review
Mechanism of Traditional Chinese Medicine Regulating JAK/STAT Signaling Pathway to Intervene in Lung Cancer: A Review
Effect of Guiqi Yiyuan Ointment on Lewis Lung Cancer Mice by Increasing Autophagic Flux and Stabilizing PD-L1 Expression Through Regulation of ERK Signaling Pathway
Chinese Medicine Regulates Ferroptosis to Treat Lung Cancer: A Review
Related Author
WANG Xinxin
GUO Junhui
LI Honglin
ZHENG Fengyu
LI Jia
SUN Xu
ZHANG Lu
LIU Huaimin
Related Institution
Henan Province Hospital of Traditional Chinese Medicine
The Second Clinical Medical College, Henan University of Chinese Medicine
The Affiliated Cancer Hospital of Zhengzhou University/Henan Cancer Hospital
Henan Province Hospital of Traditional Chinese Medicine/The Second Affiliated Hospital of Henan University of Chinese Medicine
School of Basic Medicine, Gansu University of Chinese Medicine